These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28976297)

  • 1. Analysis of tumour-immune evasion with chemo-immuno therapeutic treatment with quadratic optimal control.
    Ravindran NS; Sheriff MM; Krishnapriya P
    J Biol Dyn; 2017 Dec; 11(1):480-503. PubMed ID: 28976297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of radio-chemotherapy on tumour cells interaction with optimal control and sensitivity analysis.
    Kumar A; Dubey US; Dubey B
    Math Biosci; 2024 Mar; 369():109146. PubMed ID: 38246323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delay differential model for tumour-immune response with chemoimmunotherapy and optimal control.
    Rihan FA; Abdelrahman DH; Al-Maskari F; Ibrahim F; Abdeen MA
    Comput Math Methods Med; 2014; 2014():982978. PubMed ID: 25197319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer immunotherapy, mathematical modeling and optimal control.
    Castiglione F; Piccoli B
    J Theor Biol; 2007 Aug; 247(4):723-32. PubMed ID: 17543345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of immunotherapy on the response of TICLs to solid tumour invasion.
    Mambili-Mamboundou H; Sibanda P; Malinzi J
    Math Biosci; 2014 Mar; 249():52-9. PubMed ID: 24480736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical model reveals how regulating the three phases of T-cell response could counteract immune evasion.
    Lorenzi T; Chisholm RH; Melensi M; Lorz A; Delitala M
    Immunology; 2015 Oct; 146(2):271-80. PubMed ID: 26119966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dynamical model of tumour immunotherapy.
    Frascoli F; Kim PS; Hughes BD; Landman KA
    Math Biosci; 2014 Jul; 253():50-62. PubMed ID: 24759513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mathematical model of tumour growth with Beddington-DeAngelis functional response: a case of cancer without disease.
    Wei HC
    J Biol Dyn; 2018 Dec; 12(1):194-210. PubMed ID: 29322865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical model of tumor-immune surveillance.
    Mahasa KJ; Ouifki R; Eladdadi A; Pillis L
    J Theor Biol; 2016 Sep; 404():312-330. PubMed ID: 27317864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour.
    Matzavinos A; Chaplain MA; Kuznetsov VA
    Math Med Biol; 2004 Mar; 21(1):1-34. PubMed ID: 15065736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mathematical model of viral oncology as an immuno-oncology instigator.
    Cassidy T; Humphries AR
    Math Med Biol; 2020 Feb; 37(1):117-151. PubMed ID: 31329873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifaceted kinetics of immuno-evasion from tumor dormancy.
    d'Onofrio A
    Adv Exp Med Biol; 2013; 734():111-43. PubMed ID: 23143978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying and characterising the impact of excitability in a mathematical model of tumour-immune interactions.
    Osojnik A; Gaffney EA; Davies M; Yates JWT; Byrne HM
    J Theor Biol; 2020 Sep; 501():110250. PubMed ID: 32199856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal control problems with time delays: Two case studies in biomedicine.
    Göllmann L; Maurer H
    Math Biosci Eng; 2018 Oct; 15(5):1137-1154. PubMed ID: 30380303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls.
    de Pillis LG; Gu W; Fister KR; Head T; Maples K; Murugan A; Neal T; Yoshida K
    Math Biosci; 2007 Sep; 209(1):292-315. PubMed ID: 17306310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis inhibition and tumor-immune interactions with chemotherapy by a control set-valued method.
    Kassara K; Moustafid A
    Math Biosci; 2011 Jun; 231(2):135-43. PubMed ID: 21377480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico synergism and antagonism of an anti-tumour system intervened by coupling immunotherapy and chemotherapy: a mathematical modelling approach.
    Hu WY; Zhong WR; Wang FH; Li L; Shao YZ
    Bull Math Biol; 2012 Feb; 74(2):434-52. PubMed ID: 21972030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico tumor control induced via alternating immunostimulating and immunosuppressive phases.
    Reppas AI; Alfonso JC; Hatzikirou H
    Virulence; 2016; 7(2):174-86. PubMed ID: 26305801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune selection in neoplasia: towards a microevolutionary model of cancer development.
    Pettit SJ; Seymour K; O'Flaherty E; Kirby JA
    Br J Cancer; 2000 Jun; 82(12):1900-6. PubMed ID: 10864195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour suppression by immune system through stochastic oscillations.
    Caravagna G; d'Onofrio A; Milazzo P; Barbuti R
    J Theor Biol; 2010 Aug; 265(3):336-45. PubMed ID: 20580640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.